Vivani Medical VANI Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Returns | |||||
| Return on equity | -159.6%-37.2pp | -122.4%-43.6pp | -78.8%-19.5pp | -59.4%+413pp | |
| Return on assets | -65.7%-12.0pp | -53.8%-0.8pp | -52.9%-3.8pp | -49.1%+161pp | |
| Return on invested capital | -151.4%-16.9pp | -134.5%— | —— | —— | |
| Liquidity | |||||
| Current ratio | 2.7×-0.7× | 3.4×-0.6× | 4×-2.9× | 7×+5.8× | |
| Quick ratio | 2.7×-0.7× | 3.4×-0.6× | 4×-2.9× | 7×+5.8× | |
| Cash ratio | 2.3×-1.0× | 3.3×-0.6× | 3.8×-3.0× | 6.8×+5.8× | |
| Leverage | |||||
| Debt-to-equity | 1.2×+0.1× | 1.1×+0.1× | 1×+1.0× | 0×-0.7× | |
| Debt-to-assets | 0.5×0.0× | 0.5×0.0× | 0.5×+0.4× | 0×-0.3× | |
| Per Share | |||||
| Book value per share | $0.25-21.3% | $0.32-21.6% | $0.41— | —— | |
| Valuation | |||||
| Market capitalization | $106.93M+40.0% | $68.71M+32.0% | $52.05M+20.7% | $43.11M-77.6% | |
| Enterprise value | $106.17M+19.3% | $68.34M+34.7% | $50.75M+2,235% | -$2.38M-101% | |
| Price / book | 5.7×-10.1× | 3.9×+1.4× | 2.5×+1.5× | 1×-77.2× | |
| Free cash flow yield | -24.4%+5.4pp | -31.1%+16.2pp | -47.2%-2.9pp | -44.4%— | |
| Earnings yield | -24.9%+8.0pp | -34.2%+15.1pp | -49.3%-17.1pp | -32.2%-26.8pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Vivani Medical's profit margins?
- Vivani Medical (VANI) runs a 36.3% gross margin and a -1004.9% operating margin, with a -994.1% net margin.
- Where do Vivani Medical's ratios come from?
- Every ratio is computed from Vivani Medical's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.